Wordt geladen...
Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
The immunomodulatory agent, lenalidomide, is a structural analogue of thalidomide approved by the US Food and Drug Administration for the treatment of myelodysplastic syndrome (MDS) and multiple myeloma (MM). This agent is also currently under active investigation for the treatment of chronic lympho...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3409527/ https://ncbi.nlm.nih.gov/pubmed/22888354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/513702 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|